Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CBLPath is a U.S. specialty diagnostic laboratory focused on sub-specialized anatomic pathology, molecular diagnostics, and laboratory informatics services. Founded in 1988 as Cytopath Biopsy Lab, the company built a national physician-client base by providing pathology interpretation, advanced diagnostic testing, and patient management support. CBLPath operates as a Sonic Healthcare USA laboratory and serves clinicians with a broad menu spanning surgical pathology, cytopathology, and molecular testing rather than a traditional therapeutic drug pipeline. The business appears to remain operational under the CBLPath brand following its acquisition by Sonic Healthcare. For biotech and healthcare analysts, CBLPath is best understood as a commercial diagnostics and pathology-services platform, not a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CBLPath.